|
|
J Clin Invest. 1979 June; 63(6): 1195–1202. doi: 10.1172/JCI109414. | PMCID: PMC372068 |
Complement-dependent histaminase release from human granulocytes. J J Herman, I K Rosner, A E Davis, 3rd, R S Zeiger, M A Arnaout, and H R Colten Abstract The role of particle-bound complement proteins in the induction of noncytotoxic enzyme release from human granulocytes was investigated with the use of sera genetically deficient in complement and highly purified complement components. Release of histaminase, one of two important histamine catabolizing enzymes, and beta-glucuronidase from polymorphonuclear leukocytes was solely dependent on particle-bound C3b (the larger cleavage product of the third component of complement) when fluid-phase complement was excluded. The extent of enzyme release was a function of particle-bound C3b input, was reduced by exposing the particles to C3b inactivator, and was blocked by fluid-phase C3b. Phagocytosis of the C3b-coated particles was not required for enzyme release from neutrophils. In contrast, phagocytosis of "opsonized" particles was required for noncytotoxic release of histaminase and arylsulfatase from eosinophils; other proteins, as well as C3b, were able to opsonize particles for induction of enzyme release from eosinophils. These studies suggest a dual role for complement (particularly C3) in modulating vascular permeability phenomena, i.e., release of vasoactive mediators by the action of C3a and C5a, and release of the corresponding enzymes that inactivate the mediators by C3b. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.3M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. These references are in PubMed. This may not be the complete list of references from this article. - Daniels CA, Borsos T, Rapp HJ, Snyderman R, Notkins AL. Neutralization of sensitized virus by purified components of complement. Proc Natl Acad Sci U S A. 1970 Mar;65(3):528–535. [PubMed]
- WARD PA, COCHRANE CG, MUELLER-EBERHARD HJ. THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO. J Exp Med. 1965 Aug 1;122:327–346. [PubMed]
- Johnson AR, Hugli TE, Müller-Eberhard HJ. Release of histamine from rat mast cells by the complement peptides C3a and C5a. Immunology. 1975 Jun;28(6):1067–1080. [PubMed]
- Bokisch VA, Müller-Eberhard HJ, Cochrane CG. Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. J Exp Med. 1969 May 1;129(5):1109–1130. [PubMed]
- Nilsson UR, Mandle RJ, Jr, McConnell-Mapes JA. Human C3 and C5: subunit structure and modifications by trypsin and C42-C423. J Immunol. 1975 Feb;114(2 Pt 2):815–822. [PubMed]
- Goldstein I, Hoffstein S, Gallin J, Weissmann G. Mechanisms of lysosomal enzyme release from human leukocytes: microtubule assembly and membrane fusion induced by a component of complement. Proc Natl Acad Sci U S A. 1973 Oct;70(10):2916–2920. [PubMed]
- Müller-Eberhard HJ. Complement. Annu Rev Biochem. 1975;44:697–724. [PubMed]
- Zeiger RS, Twarog FJ, Colten HR. Histaminase release from human granulocytes. J Exp Med. 1976 Oct 1;144(4):1049–1061. [PubMed]
- Zeiger RS, Colten HR. Histaminase release from human eosinophils. J Immunol. 1977 Feb;118(2):540–543. [PubMed]
- LICHTENSTEIN LM, OSLER AG. STUDIES ON THE MECHANISMS OF HYPERSENSITIVITY PHENOMENA. IX. HISTAMINE RELEASE FROM HUMAN LEUKOCYTES BY RAGWEED POLLEN ANTIGEN. J Exp Med. 1964 Oct 1;120:507–530. [PubMed]
- Zeiger RS, Yurdin DL, Twarog FJ. Histamine metabolism. I. Thin-layer radiochromatographic assays for histaminase and histidine decarboxylase enzyme activities. J Lab Clin Med. 1976 Jun;87(6):1065–1074. [PubMed]
- Böyum A. Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent. Scand J Clin Lab Invest Suppl. 1968;97:9–29. [PubMed]
- Zeiger RS, Yurdin DL, Colten HR. Histamine metabolism. II. Cellular and subcellular localization of the catabolic enzymes, histaminase and histamine methyl transferase, in human leukocytes. J Allergy Clin Immunol. 1976 Jul;58(1 Pt 2):172–179. [PubMed]
- Parrillo JE, Fauci AS. Human eosinophils. Purification and cytotoxic capability of eosinophils from patients with the hypereosinophilic syndrome. Blood. 1978 Mar;51(3):457–473. [PubMed]
- Siraganian RP, Kulczycki A, Jr, Mendoza G, Metzger H. Ionophore A-23187 induced histamine release from rat mast cells and rat basophil leukemia (RBL-1) cells. J Immunol. 1975 Dec;115(6):1599–1602. [PubMed]
- Alper CA, Rosen FS. Genetics of the complement system. Adv Hum Genet. 1976;7:141–188. [PubMed]
- NILSSON UR, MUELLER-EBERHARD HJ. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT. J Exp Med. 1965 Aug 1;122:277–298. [PubMed]
- Abramson N, Alper CA, Lachmann PJ, Rosen FS, Jandl JH. Deficiency of C3 inactivator in man. J Immunol. 1971 Jul;107(1):19–27. [PubMed]
- Ballow M, Cochrane CG. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. J Immunol. 1969 Nov;103(5):944–952. [PubMed]
- Ziegler JB, Alper CA, Rosen RS, Lachmann PJ, Sherington L. Restoration by purified C3b inactivator of complement-mediated function in vivo in a patient with C3b inactivator deficiency. J Clin Invest. 1975 Mar;55(3):668–672. [PubMed]
- Boenisch T, Alper CA. Isolation and properties of a glycine-rich beta-glycoprotein of human serum. Biochim Biophys Acta. 1970 Dec 22;221(3):529–535. [PubMed]
- Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. [PubMed]
- Wasserman SI, Goetzl EJ, Austen KF. Inactivation of slow reacting substance of anaphylaxis by human eosinophil arylsulfatase. J Immunol. 1975 Feb;114(2 Pt 1):645–649. [PubMed]
- ULMER DD, VALLEE BL, WACKER WE. Metalloenzymes and myocardial infarction. II. Malic and lactic dehydrogenase activities and zinc concentrations in serum. N Engl J Med. 1956 Sep 6;255(10):450–456. [PubMed]
- Alper CA, Colten HR, Rosen FS, Rabson AR, Macnab GM, Gear JS. Homozygous deficiency of C3 in a patient with repeated infections. Lancet. 1972 Dec 2;2(7788):1179–1181. [PubMed]
- Colten HR, Alper CA. Hemolytic efficiencies of genetic variants of human C3. J Immunol. 1972 May;108(5):1184–1187. [PubMed]
- Metcalfe DD, Gadek JE, Raphael GD, Frank MM, Kaplan AP, Kaliner M. Human eosinophil adherence to serum-treated sepharose: granule-associated enzyme release and requirement for activation of the alternative complement pathway. J Immunol. 1977 Nov;119(5):1744–1750. [PubMed]
|